Evidence map›Paper›PMID 27956496›Full record

ArticleNucleic acids research2017

The RNA-binding protein Secisbp2 differentially modulates UGA codon reassignment and RNA decay.

Noelia Fradejas-Villar, Sandra Seeher, Christine B Anderson, Michael Doengi, Bradley A Carlson, Dolph L Hatfield, Ulrich Schweizer, Michael T Howard

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Ribosome Fate during Decoding of UGA-Sec Codons.International journal of molecular sciences · 2021
    Review
  12. The Effect of tRNAInternational journal of molecular sciences · 2021
    Article
  13. Article
  14. Review
  15. SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Bioinformatics of Selenoproteins.Antioxidants & redox signaling · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Noelia Fradejas-VillarInstitut für Biochemie und Molekularbiologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Sandra SeeherInstitut für Biochemie und Molekularbiologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Christine B AndersonDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
Michael DoengiInstitut für Physiologie II, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Bradley A CarlsonMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Dolph L HatfieldMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ulrich SchweizerInstitut für Biochemie und Molekularbiologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Michael T HowardDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
University of Bonn · DEUniversity of Utah · USCancer Genetics (United States) · USNational Cancer Institute · US

Funding

The effects of dietary selenium on translational control of protein synthesisR01GM114291 · NIGMS · UNIVERSITY OF UTAH · PI HOWARD, MICHAEL T · 2015 to 2022
$2.4M
Translational control of selenoprotein synthesisR21ES022716 · NIEHS · UNIVERSITY OF UTAH · PI HOWARD, MICHAEL T · 2013 to 2014
$408k
NIEHS NIH HHS R21 ES022716NIGMS NIH HHS R01 GM114291
6 · The paper itself

Abstract

Dual-assignment of codons as termination and elongation codons is used to expand the genetic code. In mammals, UGA can be reassigned to selenocysteine during translation of selenoproteins by a mechanism involving a 3΄ untranslated region (UTR) selenocysteine insertion sequence (SECIS) and the SECIS-binding protein Secisbp2. Here, we present data from ribosome profiling, RNA-Seq and mRNA half-life measurements that support distinct roles for Secisbp2 in UGA-redefinition and mRNA stability. Conditional deletions of the Secisbp2 and Trsp (tRNASec) genes in mouse liver were compared to determine if the effects of Secisbp2 loss on selenoprotein synthesis could be attributed entirely to the inability to incorporate Sec. As expected, tRNASec depletion resulted in loss of ribosome density downstream of all UGA-Sec codons. In contrast, the absence of Secisbp2 resulted in variable effects on ribosome density downstream of UGA-Sec codons that demonstrate gene-specific differences in Sec incorporation. For several selenoproteins in which loss of Secisbp2 resulted in greatly diminished mRNA levels, translational activity and Sec incorporation efficiency were shown to be unaffected on the remaining RNA. Collectively, these results demonstrate that Secisbp2 is not strictly required for Sec incorporation and has a distinct role in stabilizing mRNAs that can be separated from its effects on UGA-redefinition.

Indexed as

Codon, TerminatorRNA StabilityAnimalsCells, CulturedHepatocytesMaleMethylationMiceMice, KnockoutPeptide Chain Initiation, TranslationalProtein BiosynthesisRibosomesRNA-Binding ProteinsRNA, MessengerRNA, Transfer, Amino Acid-SpecificSelenoproteinsCodon, TerminatorRNA-Binding ProteinsRNA, MessengerRNA, Transfer, Amino Acid-SpecificSelenoproteinstRNA, selenocysteine-

Identifiers

PMID27956496
PMCPMC5397149
OpenAlexW2566074090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.